Login / Signup

Rifampicin in the Treatment of Refractory Diabetic Foot Ulcer and Diabetic Foot Osteomyelitis-an Observational Study.

Ghanshyam GoyalSujoy MajumdarUsashi B BoseRekha ShrivastavaSatish P BankaJugal K SharmaEdward B Jude
Published in: The international journal of lower extremity wounds (2024)
Rifampicin used in conjunction with other standard poly-microbial therapy in refractory complex diabetic foot ulcer unresponsive to standard antimicrobial therapy, can significantly improve wound healing as well as decrease the need for amputation in addition to standard of care.
Keyphrases
  • mycobacterium tuberculosis
  • wound healing
  • healthcare
  • palliative care
  • staphylococcus aureus
  • pulmonary tuberculosis
  • stem cells
  • quality improvement
  • lower limb
  • combination therapy
  • cell therapy
  • smoking cessation